75. Cushing disease Clinical trials / Disease details

Clinical trials : 203 /  Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04569591
(ClinicalTrials.gov)		March 24, 202229/9/2020Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s DiseaseCorticotrophin-Releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing's DiseaseCushing's Disease;Pituitary AdenomaDrug: ActhrelNational Institute of Neurological Disorders and Stroke (NINDS)NULLNot yet recruiting8 YearsN/AAll22N/AUnited States
2NCT01459237
(ClinicalTrials.gov)		October 11, 201121/10/2011Effects of Hormone Stimulation on Brain Scans for Cushing s DiseaseProspective Evaluation of the Effect of Corticotropin-Releasing Hormone Stimulation on 18F-Fludeoxyglucose High-Resolution Positron-Emission Tomography in Cushing's DiseasePituitary NeoplasmDrug: ActhrelNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompleted8 YearsN/AAll30Early Phase 1United States